An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients

被引：4
|
作者：
Chakravarti, A.
Berkey, B.
Robins, H. I.
Guha, A.
Curran, W.
Brachman, D.
Shultz, C.
Mehta, M.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Amer Coll Radiol, Philadelphia, PA USA
[3] Univ Wisconsin, Madison, WI USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Thomas Jefferson Med Coll, Philadelphia, PA USA
[6] Fdn Canc Res, Phoenix, AZ USA
[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [1] An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib plus radiation for newly-diagnosed glioblastoma (GBM) patients.
    Chakravarti, A
    Seiferheld, W
    Robins, HI
    Guha, A
    Brachman, D
    Curran, W
    Choucair, A
    Mehta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 124S - 124S
  • [2] An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma multiforme
    Chakravarti, A.
    Berkey, B.
    Robins, I.
    Guha, A.
    Curran, W.
    Brachman, D.
    Shultz, C.
    Mehta, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 439 - 439
  • [3] An update on correlative molecular Endpoints from RTOG 0211: Phase I/II study of gefitinib plus radiation for newly diagnosed glioblastoma patients
    Chakravarti, A.
    Wang, M.
    Mischel, P.
    Robins, H. I.
    Guha, A.
    Machtay, M.
    Curran, W.
    Roach, M.
    Mehta, M.
    Dicker, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S9 - S10
  • [4] AN UPDATE ON CORRELATIVE MOLECULAR ENDPOINTS FROM RTOG 0211: PHASE I/II STUDY OF GEFITINIB plus RADIATION FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Chakravartti, A.
    Wang, M.
    Mischel, P.
    Robins, H. I.
    Guha, A.
    Machray, M.
    Curran, W.
    Roach, M.
    Mehta, M.
    Dicker, A.
    NEURO-ONCOLOGY, 2008, 10 (05) : 785 - 785
  • [5] An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients
    Chakravarti, A
    Seiferheld, W
    Robins, HI
    Guha, A
    Brachman, D
    Curran, W
    Choucair, A
    Mehta, M
    NEURO-ONCOLOGY, 2004, 6 (04) : 372 - 372
  • [6] An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastorna.
    Chakravarti, A.
    Berkey, B.
    Robins, H. I.
    Guha, A.
    Curran, W. J.
    Brachman, D.
    Shultz, C.
    Mehta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 64S - 64S
  • [7] RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
    Chakravarti, Arnab
    Wang, Meihua
    Robins, H. Ian
    Lautenschlaeger, Tim
    Curran, Walter J.
    Brachman, David G.
    Schultz, Christopher J.
    Choucair, Ali
    Dolled-Filhart, Marisa
    Christiansen, Jason
    Gustavson, Mark
    Molinaro, Annette
    Mischel, Paul
    Dicker, Adam P.
    Bredel, Markus
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1206 - 1211
  • [8] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Alexander, Brian M.
    Wang, Meihua
    Yung, W. K. Alfred
    Fine, Howard A.
    Donahue, Bernadine A.
    Tremont, Ivo W.
    Richards, Ray S.
    Kerlin, Kevin J.
    Hartford, Alan C.
    Curran, Walter J.
    Mehta, Minesh P.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (01) : 33 - 39
  • [9] A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
    Brian M. Alexander
    Meihua Wang
    W. K. Alfred Yung
    Howard A. Fine
    Bernadine A. Donahue
    Ivo W. Tremont
    Ray S. Richards
    Kevin J. Kerlin
    Alan C. Hartford
    Walter J. Curran
    Minesh P. Mehta
    Journal of Neuro-Oncology, 2013, 111 : 33 - 39
  • [10] AVASTIN AND TEMOZOLOMIDE FOLLOWING RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PHASE II STUDY
    Nicholas, M. K.
    Chmura, S.
    Paleologos, Nina
    Krouwer, Hendrikus
    Malkin, Mark
    Junck, Larry
    Vick, Nicholas A.
    Lukas, Rimas V.
    NEURO-ONCOLOGY, 2011, 13 : 88 - 89
12345